PT1896021E - Composição farmacêutica sólida contendo (r)-(-)-2-[5-(4- fluorfenil)-3-piridilmetilaminometil]-cromano - Google Patents

Composição farmacêutica sólida contendo (r)-(-)-2-[5-(4- fluorfenil)-3-piridilmetilaminometil]-cromano Download PDF

Info

Publication number
PT1896021E
PT1896021E PT06754265T PT06754265T PT1896021E PT 1896021 E PT1896021 E PT 1896021E PT 06754265 T PT06754265 T PT 06754265T PT 06754265 T PT06754265 T PT 06754265T PT 1896021 E PT1896021 E PT 1896021E
Authority
PT
Portugal
Prior art keywords
pyridylmethylaminomethyl
chroman
fluorophenyl
pharmaceutical preparation
preparation containing
Prior art date
Application number
PT06754265T
Other languages
English (en)
Inventor
Roland Rupp
Klaus Kunath
Kirstin Heil
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of PT1896021E publication Critical patent/PT1896021E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4433Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT06754265T 2005-06-21 2006-06-09 Composição farmacêutica sólida contendo (r)-(-)-2-[5-(4- fluorfenil)-3-piridilmetilaminometil]-cromano PT1896021E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05013293 2005-06-21

Publications (1)

Publication Number Publication Date
PT1896021E true PT1896021E (pt) 2009-07-20

Family

ID=36809668

Family Applications (1)

Application Number Title Priority Date Filing Date
PT06754265T PT1896021E (pt) 2005-06-21 2006-06-09 Composição farmacêutica sólida contendo (r)-(-)-2-[5-(4- fluorfenil)-3-piridilmetilaminometil]-cromano

Country Status (17)

Country Link
US (1) US8093270B2 (pt)
EP (1) EP1896021B1 (pt)
JP (1) JP5139275B2 (pt)
KR (1) KR101306088B1 (pt)
CN (1) CN101198328B (pt)
AR (1) AR054487A1 (pt)
AT (1) ATE428416T1 (pt)
AU (1) AU2006261314B2 (pt)
BR (1) BRPI0612752B8 (pt)
CA (1) CA2612738C (pt)
DE (1) DE502006003465D1 (pt)
ES (1) ES2322777T3 (pt)
MX (1) MX2007015359A (pt)
PT (1) PT1896021E (pt)
RU (1) RU2405547C2 (pt)
WO (1) WO2006136302A1 (pt)
ZA (1) ZA200800553B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101978953A (zh) * 2010-10-11 2011-02-23 上海交通大学 基于易吸湿性辅料的固体制剂

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4327077A (en) * 1981-05-29 1982-04-27 Life Savers, Inc. Compressed chewable antacid tablet and method for forming same
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
DE19508192A1 (de) * 1995-03-09 1996-09-12 Behringwerke Ag Stabile Transglutaminasepräparate und Verfahren zu ihrer Herstellung
JPH1053529A (ja) * 1996-06-07 1998-02-24 Takeda Chem Ind Ltd 固形製剤
JPH10203971A (ja) * 1996-11-19 1998-08-04 Takeda Chem Ind Ltd 水性経口液剤
JPH11189547A (ja) * 1997-12-26 1999-07-13 Taisho Pharmaceut Co Ltd 安定化されたニコランジル製剤及びその製造方法
FR2775188B1 (fr) * 1998-02-23 2001-03-09 Lipha Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption
JP4063390B2 (ja) * 1998-03-06 2008-03-19 三菱商事フードテック株式会社 錠剤の製造方法
UA73981C2 (en) * 2000-03-10 2005-10-17 Merck Patent Gmbh (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit
JP3595765B2 (ja) * 2000-09-27 2004-12-02 信越化学工業株式会社 低置換度ヒドロキシプロピルセルロースを含む乾式直打用基剤
PT1343518E (pt) * 2000-11-07 2009-08-03 Novartis Vaccines & Diagnostic Composições de interferão estabilizadas
DE10120619A1 (de) * 2001-04-26 2002-10-31 Merck Patent Gmbh 2-(5-(4-Fluorphenyl)-3-pyridylmethylaminomethyl-chroman

Also Published As

Publication number Publication date
BRPI0612752B8 (pt) 2021-05-25
CN101198328B (zh) 2011-04-06
AR054487A1 (es) 2007-06-27
DE502006003465D1 (de) 2009-05-28
RU2008101364A (ru) 2009-07-27
US8093270B2 (en) 2012-01-10
JP5139275B2 (ja) 2013-02-06
ES2322777T3 (es) 2009-06-26
EP1896021B1 (de) 2009-04-15
BRPI0612752A2 (pt) 2010-11-30
RU2405547C2 (ru) 2010-12-10
ZA200800553B (en) 2008-12-31
ATE428416T1 (de) 2009-05-15
KR101306088B1 (ko) 2013-09-09
AU2006261314A1 (en) 2006-12-28
KR20080030029A (ko) 2008-04-03
MX2007015359A (es) 2008-02-15
CN101198328A (zh) 2008-06-11
AU2006261314B2 (en) 2012-03-22
CA2612738A1 (en) 2006-12-28
BRPI0612752B1 (pt) 2019-08-20
JP2008543894A (ja) 2008-12-04
CA2612738C (en) 2013-11-26
WO2006136302A1 (de) 2006-12-28
EP1896021A1 (de) 2008-03-12
US20100105648A1 (en) 2010-04-29

Similar Documents

Publication Publication Date Title
ZA200606154B (en) Pharmaceutical composition comprising pimobendan
IL223545A0 (en) Pharmaceutical compositions
ZA200801275B (en) Pharmaceutical preparation containing meloxicam
IL179809A0 (en) Pharmaceutical compositions
IL177480A0 (en) Pharmaceutical composition
GB0408308D0 (en) Pharmaceutical compositions
IL178689A0 (en) Pharmaceutical solution formulations containing 17-aag
PL1837019T3 (pl) Kompozycja farmaceutyczna rozpadająca się w ustach
EP1805154A4 (en) PHARMACEUTICAL COMPOSITIONS
EP1778252A4 (en) NON-CARDIOTOXIC PHARMACEUTICAL COMPOUNDS
HU0401177D0 (en) Pharmaceutical composition
GB2411355B (en) Pharmaceutical composition
ZA200701932B (en) Pharmaceutical composition
GB0425255D0 (en) Pharmaceutical composition
ZA200701931B (en) Pharmaceutical composition
PT1896021E (pt) Composição farmacêutica sólida contendo (r)-(-)-2-[5-(4- fluorfenil)-3-piridilmetilaminometil]-cromano
EP1747205A4 (en) PHARMACEUTICAL COMPOSITIONS
GB0502792D0 (en) Pharmaceutical compositions
GB0400971D0 (en) Pharmaceutical compositions
GB0411502D0 (en) Pharmaceutical compositions
GB0407351D0 (en) Pharmaceutical compositions
GB0402799D0 (en) Pharmaceutical composition
GB0422572D0 (en) Pharmaceutical compositions
GB0420173D0 (en) Pharmaceutical compositions
GB0425728D0 (en) Pharmaceutical compositions